Chemoinformaics analysis of homovanilic acid
| Molecular Weight | 27.026 | nRot | 0 |
| Heavy Atom Molecular Weight | 26.018 | nRig | 3 |
| Exact Molecular Weight | 27.0109 | nRing | 0 |
| Solubility: LogS | -3.563 | nHRing | 0 |
| Solubility: LogP | 3.872 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 3 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 2 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 1 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 1 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 3.43679 |
| nHD | 0 | BPOL | 1.57321 |
| QED | 0.51 |
| Synth | 3.114 |
| Natural Product Likeliness | 2.833 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.032 |
| HIA | 0.006 |
| CACO-2 | -4.352 |
| MDCK | 0.0000216 |
| BBB | 0.323 |
| PPB | 0.870549 |
| VDSS | 3.265 |
| FU | 0.167188 |
| CYP1A2-inh | 0.59 |
| CYP1A2-sub | 0.938 |
| CYP2c19-inh | 0.199 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.77 |
| CYP2d6-inh | 0.266 |
| CYP2d6-sub | 0.919 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.497 |
| CL | 5.301 |
| T12 | 0.843 |
| hERG | 0.044 |
| Ames | 0.162 |
| ROA | 0.108 |
| SkinSen | 0.946 |
| Carcinogencity | 0.327 |
| EI | 0.977 |
| Respiratory | 0.95 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.922667 |